Argosy Minerals Limited (ASX) Shares Rocketing High on ASX After Confirmed Production of 99.6% Lithium Carbonate Product


Argosy Minerals Limited (ASX: AGY) informed the market that the group has successfully produced initial “battery grade” of lithium carbonate product from its stage 1 plant at the Rincon lithium project, located in Salta Province, Argentina. In which, the company has completed an efficient production of 30 kilograms of LCE product and recorded 99.6% of the content value of a Lithium Carbonate (Li2CO3) during in-house testing. The LCE product will now be prepared for customer samples for their own quality confirmation and testing and sent to end-user customers.

According to the management, the group has achieved a remarkable success from its Stage 1 plant in the capacity of 500 tonnes per annum (tpa) and expects that the completed process test-works phase to date will form the basis to further improve and optimise the production process for subsequent commercial sales and substantiate the Stage 2 and Stage 3 commercial plant designs.

With this news, the stock scaled up 61.11 per cent with the intra-trading volume of more than 18 Mn. The stock traded at $0.29 with the market-cap of circa $165.33 Mn as on August 06, 2018 (AEST – 3:30 P.M.).

Dividend Stocks To Buy

The Income available from dividends remains attractive for many investors.

We take a look at the best yields on the market and assess what they say about a company’s prospect.

One Thing is certain, though, Australia interest rates are still low, making income difficult to come by and keeping the focus for many investors on high yielding stocks. Kalkine’s team of analysts bought you handpicked report for “Top 25 Dividend Stocks For 2018.”

ASX-relevant Special Reports are published year-round to provide a detailed analysis into an investing opportunity or a potential risk to your portfolio.

Click here to get your free report.


The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.

Join Our Discussion

Start discussion with value Investors for ASX Stock Market Investment and Opinion.

6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report